Ángel Rubín - Concepedia

Author

Ángel Rubín

Hospital Universitari i Politècnic La Fe

Also Known As

A L Rubin, A Rubín, A. Rubin, A. Rubín, Angel Rubin, Angel Rubín, Ángel Rubin, Ángel Rubín

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

Hospital Universitari i Politècnic La Fe Universitat de València Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas Hospital Universitario Reina Sofía Bellvitge University Hospital

ÁR

About

Ángel Rubín is an author at Hospital Universitari i Politècnic La Fe specializing in medicine, hepatology, and liver transplantation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	11	1K
2	Engineering	1	1	151
3	Health Sciences	1	1	364
4	Public Health	1	1	48
5	Epidemiology	1	1	48

Ángel Rubín

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial Josep M. Llovet, Masatoshi Kudo, Philippe Merle, The Lancet Oncology OncologyHepatologyMedicineClinical TrialsPembrolizumab Versus Lenvatinib	2023	364
Use of artificial intelligence as an innovative donor-recipient matching model for liver transplantation: Results from a multicenter Spanish study Javier Briceño, M. Cruz-Ramírez, M. Prieto, Journal of Hepatology Artificial IntelligenceOrgan DonationTransplantationHepatologyEngineering	2014	151
Evaluation of postsurgical recurrence in Crohn's disease: a new indication for capsule endoscopy? Vicente Pons, Pilar Nos, Guillermo Bastida, Gastrointestinal Endoscopy New IndicationCapsule EndoscopyGastroenterologyGi TechniqueSurgery	2007	149
Clinical outcomes of patients undergoing antiviral therapy while awaiting liver transplantation J.M. Pascasio, Carmen Vinaixa, M.T. Ferrer, Journal of Hepatology TransplantationHepatologySolid Organ TransplantationAntiviral TherapyVirology	2017	127
Worse Recent Efficacy of Antiviral Therapy in Liver Transplant Recipients with Recurrent Hepatitis C: Impact of Donor Age and Baseline Cirrhosis Marina Berenguer, Victoria Aguilera, M. Prieto, Liver Transplantation	2009	69
Long-term outcome of ‘long-term liver transplant survivors’ Ángel Rubín, Cristina Sánchez-Montes, Victoria Aguilera, Transplant International	2013	65
Effect of Calcineurin Inhibitors in the Outcome of Liver Transplantation in Hepatitis C Virus-Positive Recipients Marina Berenguer, Victoria Aguilera, Fernando San Juan, Transplantation	2010	62
Cirrhosis of Mixed Etiology (Hepatitis C Virus and Alcohol): Posttransplantation Outcome—Comparison with Hepatitis C Virus–Related Cirrhosis and Alcoholic-Related Cirrhosis Victoria Aguilera, Marina Berenguer, Ángel Rubín, Liver Transplantation	2008	50
Framingham score, renal dysfunction, and cardiovascular risk in liver transplant patients Tommaso Di Maira, Ángel Rubín, Lorena Puchades, Liver Transplantation Heart FailureSolid Organ TransplantationFramingham ScoreLogistic AnalysisCoronary Artery Disease	2015	48
Deep-sequencing reveals broad subtype-specific HCV resistance mutations associated with treatment failure Qian Chen, Celia Perales, María Eugenia Soria, Antiviral Research Viral HepatitisMedicinePathogenesisNext-generation SequencingPathology	2019	45

Page 1